Asthma Surveillance and Education in Preschool Settings

This study is currently recruiting participants.

Verified by National Heart, Lung, and Blood Institute (NHLBI), April 2007

Sponsored by:	National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:	National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:	NCT00201071

Purpose

The purpose of this study is to test the effectiveness of a bilingual intervention in improving asthma care for low-income inner-city children enrolled in subsidized preschool childcare programs.

Condition
Asthma

MedlinePlus related topics: Asthma

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History, Prospective Study
Official Title:	Asthma Surveillance and Education in Preschool Settings

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Estimated Enrollment:	240
Study Start Date:	September 2004

Detailed Description:

BACKGROUND:

Proposed is a non-randomized, controlled, prospective trial to test the efficacy of a bilingual intervention to improve asthma care for low-income inner-city children enrolled in subsidized preschool childcare programs. Because of high rates of asthma prevalence, subsidized preschool childcare programs offer ideal settings to test innovative strategies to improve asthma care within communities at highest risk of morbidity.

DESIGN NARRATIVE:

The study will comprise three arms. Arm 1 is surveillance, in which children with asthma are identified. In Arm 2, children with asthma are identified and given written Asthma Action Plans (monitoring). Arm 3 consists of surveillance, monitoring, and education.

Eligibility

Ages Eligible for Study:	2 Years to 4 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Enrolled in specific subsidized preschools in New York City
2.8 to 4 years old
Persistent asthma as defined by symptom reports
Use of quick-relief agents or controller medications

Exclusion Criteria:

History of intubation

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00201071

Locations

United States, New York
The New York Academy of Medicine, CUES	Recruiting
New York, New York, United States, 10029
Contact: Micaela Coady, MS 212-822-7277 mcoady@nyam.org
Principal Investigator: Sebastian Bonner, PhD

Sponsors and Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

Principal Investigator:

Sebastian Bonner, PhD

The New York Academy of Medicine, CUES

More Information

Click here for the New York Academy of Medicine website This link exits the ClinicalTrials.gov site

Study ID Numbers:	1298, R01 HL076592
Study First Received:	September 12, 2005
Last Updated:	April 27, 2007
ClinicalTrials.gov Identifier:	NCT00201071
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Hypersensitivity
Lung Diseases, Obstructive
Respiratory Tract Diseases
Lung Diseases

Hypersensitivity, Immediate
Asthma
Respiratory Hypersensitivity

Additional relevant MeSH terms:

Immune System Diseases
Bronchial Diseases

ClinicalTrials.gov processed this record on January 16, 2009